Harvest & Collection
PRODUCTS
-
StabilityPlus™, phase-stable cable assemblies, are designed for high-performance, ruggedized microwave/RF applications. They offer excellent measurement repeatability and durability, reducing the total cost-of-test.
-
Effective RTSM, built on 30 years of experience
Backed by the industry’s most experienced designers and RTSM specialists, you can rely on Perceptive eClinical to deliver optimized randomization and trial supply management (RTSM) strategies that keep trials on track, even when they don’t go according to plan – and they never go according to plan.
-
The AMP2043P-2KW is a solid-state high-power pulse amplifier catering to EMI/RFI, lab, and HIRF/Pulse applications that offers a Class AB linear design with an instantaneous L-Band octave bandwidth.
-
QPA1314 is a high-power GaN MMIC amplifier for Satcom applications. The amplifier is packaged for easy integration and is ideal for both commercial and military markets.
-
More than just an electronic data collection tool, our robust clinical data management system combines an intuitive user interface, seamless online and offline data capture capabilities, and comprehensive data management for clinical trials in a single solution.
WHITE PAPERS AND CASE STUDIES
-
Performance Dashboards Development
Learn about a biotech company's successful implementation of a two-level KPI dashboard system. This enhanced performance monitoring, aligned departmental goals, and strengthened team communication.
-
The Role Of Hexapods In High-Precision Machining
A custom hexapod was introduced at ILA Berlin 2024, enhancing precision in aircraft construction. This 6-DOF system improves contour machining of CFRP components, reducing manufacturing times and costs.
-
CRO Uses CRIO eSource To Double Monitoring Productivity
Examine the transformative impact of eSource technology on monitoring productivity during a global Phase 3 trial conducted by a Contract Research Organization (CRO) amid the COVID-19 pandemic.
-
Successful Cell-Based ADA Collaboration In mRNA Gene Replacement Therapy
A biotech firm developed a rapid, sensitive, cell-based ADA assay through collaborative innovation, reducing variability and turnaround time while improving performance for mRNA gene therapy.
-
BioIVT Collaborates With IDBS To Deploy IDBS E-WorkBook And Reduce Study Cycle Times
Learn about a collaboration that has enabled BioIVT to enhance efficiency and responsiveness to its biopharmaceutical clients.
-
Scalable FSP Model For Managing IVD Clinical Trials In A Niche Market
Here, we illustrate the advantages of our FSP services, including enhanced scalability, risk mitigation, cost efficiency, and timely project completion.
-
How Strategic Valve Installation Prevented Service Disruption at a Senior Living Facility
Learn how Hydra-Stop’s insertion valve provided new control points to mitigate future disruptions during a service line emergency.
-
Developing Amorphous Solid Dispersions For Poorly Soluble Drugs
Discover how a strategic amorphous solid dispersion approach improved bioavailability and advanced a low-solubility compound toward clinical readiness in just four weeks.
-
How To Tackle Water Scarcity In A City Of 22 Million People
Making Waves spoke with Bing Liu, Sales GM of Xylem’s Water Infrastructure business in China, about the country’s growing water reuse opportunity and one utility leader that is leading the way: Beijing Drainage Group.
-
Pilot Study To Compare Single-Use IEX Resin To GAC Moved To Full-Scale Certified Drinking Water System
In a high-stakes effort to protect the drinking water for 10,000 people near the Pease Air Force Base in Portsmouth, NH, ECT2 spearheaded a pilot study to combat PFAS contamination in the region's water supply.
-
How Sharp Packaging's Clinical Packaging Process Is 30% Faster
Discover how digitized workflows and real-time verification are helping streamline clinical trial packaging, reduce complexity, and improve quality in a high-stakes, time-sensitive environment.
-
Early-Stage Development In Rare Pediatric Oncology
Learn about the strategic approach a biotechnology company utilized to address significant hurdles in launching a Phase 1 clinical trial for a novel therapy targeting a rare pediatric cancer.
NEWS
-
Canada Accelerates Transition To Zero-Emissions Vehicles8/13/2025
Canada is leading the way on the infrastructure, innovation and partnerships required to transition to electric transportation.
-
Drawing Inspiration From Ancient Chemical Reactions3/20/2025
To help find solutions to the planet’s climate crisis, MIT Associate Professor Daniel Suess is looking to Earth’s ancient past.
-
Motivosity Launches Lifestyle Spending Accounts To Help Companies Offer Flexible, Hassle-Free Employee Perks5/27/2025
Motivosity, the leading people-first employee recognition and rewards platform built for today’s workforce, is proud to announce the launch of its new Lifestyle Spending Accounts (LSAs) program.
-
Plants Don't Just Feel The Heat – They Decode It Through A Molecular Network6/13/2025
In a new framework that could reshape how we engineer crops for a warming world, scientists have revealed that plants don't rely on a single "thermometer" to sense temperature.
-
Enhanc3D Genomics Launches Suite Of 3D Multi-Omics Solutions To Accelerate Drug Development1/14/2025
Enhanc3D Genomics (‘Enhanced’ or ‘the Company’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery.
ABOUT
Harvest and Collection
Harvest and collection is the process used to retrieve biological agents and vaccines present in cell cultures or to harvest and collect stem cells from blood or bone marrow. Many bioresearch companies have sophisticated systems for harvesting and collecting cells. These systems make counting cells easier and they also protect against contamination.
Cells are harvested once the cells reach a density level in the cell culture medium that precludes further growth. The best time to harvest cells is when they are in a confluent state (at least 50% of the culture dish is covered and before 100% of the dish is covered).
Cells can be harvested using on of three methods: Mechanical, using Proteolytic enzymes, or using EDTA. Mechanical harvesting uses a rubber spatula to remove the cells from the growth surface or culture. This method is quick but can cause many cells to die because it is highly disruptive. This method is favored when harvesting lots of different samples of cells to prepare extracts.
In this case, viability of the cells doesn’t matter. Three enzymes; Trypsin, Collagenase, and Pronase can be used in combination with EDTA. The combination of these enzymes with the EDTA makes cells detach from the growth medium.
This method is easy but also has a downside. It can damage the cell surface by eating up exposed cell surface proteins. EDTA can be used alone to detach cells from their medium and it is gentler than using trypsin.
Normally, collected cells are placed in a new suspension, or growth medium to continue growing new cultures. This is referred to as passaging or splitting the cells.